Rigel Pharma (RIGL) Misses Q4 EPS by 5c
Tweet
Share
E-mailGet Alerts RIGL Hot Sheet
Price: $43.62 +2.76%
Financial Fact:
Contract revenues from collaborations: 3.76M
Today's EPS Names:
SCWO, HSAI, SYRS, More
Financial Fact:
Contract revenues from collaborations: 3.76M
Today's EPS Names:
SCWO, HSAI, SYRS, More
Join SI Premium – FREE
Rigel Pharma (NASDAQ: RIGL) reported Q4 EPS of ($0.18), $0.05 worse than the analyst estimate of ($0.13).
For earnings history and earnings-related data on Rigel Pharma (RIGL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Klarna shares tumble on weak full-year revenue guidance
- 374Water Inc (SCWO) Misses Q2 EPS by 15c
- Klarna Group plc (KLAR) Tops Q2 EPS by 6c, Beats on Revenue; Offers FY26 Revenue Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
